Skip to main content

Want a detailed portfolio tracker?

SOLV
NYSE
$79.25

Solventum Corp (SOLV)

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. The company is headquartered in Saint Paul, Minnesota.
Website: https://www.solventum.com
68 analysts
Hold
Target: $83.38 (+5.21%)

Market Cap

$14B

PEG Ratio

0.03

P/E Ratio

9.49

Free Cash Flow Yield

-1.49%

Price Chart

Valuation
Market Cap$14B
P/E9.49
Forward P/E12.41
PEG0.03
P/S1.64
P/B2.66
Profitability
Total Revenue (TTM)$8.26B
Gross Profit (TTM)$4.43B
EBITDA$2.60B
Profit Margin0.7%
Operating Margin4%
EPS$8.26
Financial Health
Debt-to-Equity102.2%
Free Cash Flow Yield-1.49%
Growth & Risk
Beta (5Y)0.85
Sharpe Ratio0.26